Basit öğe kaydını göster

dc.contributor.authorCelebier, Mustafa
dc.contributor.authorKaynak, Mustafa Sinan
dc.contributor.authorAltinoz, Sacide
dc.contributor.authorSahin, Selma
dc.date.accessioned2019-12-16T10:29:10Z
dc.date.available2019-12-16T10:29:10Z
dc.date.issued2014
dc.identifier.issn1521-298X
dc.identifier.urihttps://doi.org/10.14227/DT210414P56
dc.identifier.urihttp://hdl.handle.net/11655/20064
dc.description.abstractRivaroxaban is an oral anticoagulant that is the first available orally active direct Factor Xa inhibitor. In this study, a UV spectrophotometric method was developed for the determination of rivaroxaban content in pharmaceutical formulations and the amount of rivaroxaban released in tablet dissolution studies. The dissolution profile of rivaroxaban was successfully determined with the validated method.
dc.language.isoen
dc.publisherDissolution Technologies, Inc
dc.relation.isversionof10.14227/DT210414P56
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPharmacology & Pharmacy
dc.titleUv Spectrophotometric Method For Determination Of The Dissolution Profile Of Rivaroxaban
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalDissolution Technologies
dc.contributor.departmentAnalitik Kimya
dc.identifier.volume21
dc.identifier.issue4
dc.identifier.startpage56
dc.identifier.endpage59
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster